Page last updated: 2024-11-02

oxidopamine and Fibrosarcoma

oxidopamine has been researched along with Fibrosarcoma in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lackovicova, L1
Banovska, L1
Bundzikova, J1
Janega, P1
Bizik, J1
Kiss, A1
Mravec, B1

Other Studies

1 other study available for oxidopamine and Fibrosarcoma

ArticleYear
Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.
    Neoplasma, 2011, Volume: 58, Issue:5

    Topics: Animals; Body Weight; Fibrosarcoma; Humans; Immunoenzyme Techniques; Injections, Intraperitoneal; Ma

2011